Justin Burgess Sells $36.7K of Dynavax Technologies Corp (DVAX) — SEC Form 4, Mar 26, 2021
This is an amended filing (Form 4/A) — it supersedes the original filed March 02, 2021.
Open-Market Net Sale · SEC Form 4
−$36,728
Equity position changed by +123.2%
Equity Position
11.1K sh
4,989 → 11,133
Equity Change
+123.2%
shares held after vs before
Filing Lag
18 business days
late vs 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Justin Burgess CIK 0001812025 |
CAO
|
Justin Burgess at Dynavax Technologies Corp
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Dynavax Technologies Corp
| 2025-02-12 | Exercise | — | View |
| 2024-03-19 | Award | — | View |
| 2024-03-04 | Sell | -$262,322 | View |
| 2024-02-20 | Exercise | — | View |
| 2024-02-13 | Exercise | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF4 | 2021-03-01 | M - Exercise | 2,839 A | — | 11,133 | Direct | |
| Common StockF5 | 2021-03-01 | S - Sale | 1,325 D | $8.88 | -$11,766 | 9,808 | Direct |
| Common StockF6 | 2021-03-01 | S - Sale | 1,633 D | $8.88 | -$14,501 | 8,175 | Direct |
| Common StockF7 | 2021-03-02 | S - Sale | 1,186 D | $8.82 | -$10,461 | 6,989 | Direct |
| Common StockF3 | 2021-02-26 | M - Exercise | 3,906 A | — | 8,294 | Direct | |
| Common StockF1 | 2021-02-12 | A - Award/Grant | 376 A | $3.39 | +$1,275 | 1,221 | Direct |
| Common StockF2 | 2021-02-26 | M - Exercise | 3,167 A | — | 4,388 | Direct |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2F2F2F2 | 2021-02-26 | M - Exercise | 3,167 D | 3,167 Common Stock | Direct | |||
| Restricted Stock UnitF3F3F3F3 | 2021-02-26 | M - Exercise | 3,906 D | 3,906 Common Stock | Direct | |||
| Restricted Stock UnitF4F4F4F4 | 2021-03-01 | M - Exercise | 2,839 D | 2,839 Common Stock | Direct |
Footnotes (7)
- F1
- Represents 376 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 12, 2021 Show more
- F2
- Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 12, 2020. Delivery of the shares in settlement of the RSUs was deferred to February 26, 2021. Show more
- F3
- Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 22, 2019. Delivery of the shares in settlement of the RSUs was deferred to February 26, 2021. Show more
- F4
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of March 1, 2018. Show more
- F5
- The reporting person is reporting the sale of 1,325 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 26, 2021. Show more
- F6
- The reporting person is reporting the sale of 1,633 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 26, 2021. Show more
- F7
- The reporting person is reporting the sale of 1,186 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on March 1, 2021. Show more
Remarks
This amendment to Form 4 is being filed solely to correct the number of shares reflected as being sold in footnote 7 to the Form 4 filed on March 2, 2021, from 1,165 shares to 1,186 shares.
Show moreRelated filings at Dynavax Technologies Corp
5%+ Holders · 13D/G
1 filer
-
Black Rock, Inc. 14.2%
Other insiders at Dynavax Technologies Corp
GET /v1/forms/4/0001209191-21-023324
API docs
View Original SEC Filing